A modular system to evaluate the efficacy of protease inhibitors against HIV-2.
The human immunodeficiency virus (HIV) protease is a homodimeric aspartyl protease that is crucial for the viral life-cycle, cleaving proviral polyproteins, hence creating mature protein components that are required for the formation of an infectious virus. With diagnostic measures and clinically us...
Saved in:
| Main Authors: | Mohamed Mahdi, Krisztina Matúz, Ferenc Tóth, József Tőzsér |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0113221&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HIV protease inhibitors restore amphotericin B activity against Candida.
by: Yehia Elgammal, et al.
Published: (2025-01-01) -
Evaluation of COVID-19 protease and HIV inhibitors interactions
by: Tran Linh, et al.
Published: (2022-03-01) -
PRACTICE OF USING VIRAL PROTEASE INHIBITORS IN CHILDREN WITH HIV INFECTION
by: V.B. Denisenko, et al.
Published: (2010-02-01) -
From protease inhibitors to integrase strand transfer inhibitors: the evolution of HIV drug resistance management
by: HU Zhiliang, YANG Yongfeng
Published: (2025-01-01) -
In Silico Evaluation of Novel 2-Pyrazoline Carboxamide Derivatives as Potential Protease Inhibitors Against <i>Plasmodium</i> Parasites
by: Yusuf Jimoh, et al.
Published: (2024-11-01)